Answers are grounded in this paper and cite their sources.
Sentinel lymph node biopsy (SLNB) for melanoma is used less frequently in elderly patients. 1SLNB provides crucial prognostic information for adult patients with clinically localized melanoma based on the Multicenter Selective Lymphadenectomy Trial-I (MSLT-I); however, patients older than 75 years of age were excluded from this trial. 2Improved melanoma-specific survival (MSS) was seen in a latent subgroup analysis of the MSLT-I for patients with intermediate-thickness tumors whose nodal disease was discovered through SLNB rather than after a clinical recurrence. 2 In melanoma patients older than 75 years of age, institutional data from Sabel et al. (1996-2011) reported a trend toward improved MSS in patients undergoing SLNB versus those not undergoing SLNB. 3 To date, the prognostic and therapeutic benefits of SLNB in elderly patients with melanoma remains debated.
No takes yet. Share an insight, caveat, or question.
Kakish et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: